Euro12m to create European "epigenetics" network: number of other Asian countries.
This article was originally published in Clinica
European researchers have received Euro12m ($15m) to establish a European Network of Excellence in "Epigenetics". The so-called Epigenome project aims to better understand the practical applications of the information derived from mapping the human genome - commonly known as the post-genome challenge. "We now need to understand how cells make sense of the DNA codes they are given to make them a particular cell with a particular job for life, and what prompts them to keep functioning normally and replicate," said the UK's Medical Research Council, which is part of the international consortium of research bodies involved.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.